Most patients can continue semaglutide before elective surgery with appropriate risk assessment
(October 18, 2025) Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study
Injectable GLP-1 medications Standard injectable GLP-1 medications deliver the drug systemically, meaning it affects salivary glands through bloodstream distribution rather than direct oral contact
Only FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) have established safety and efficacy profiles
Early legal intervention can protect the pharmacy's rights, ensure appropriate responses to FDA or state board requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the pharmacy's behalf